Skip to content

PHARMA-BIO SERV, INC.: 10-Q filed 2011-09-14

What PHARMA-BIO SERV, INC. reported in its quarterly report filed 2011-09-14 (fiscal Q3 2011): 31 published measures, 104 facts as tagged in accession 0001354488-11-003435.

This filing

Form
10-Q (quarterly report)
Filed
2011-09-14
Fiscal period
fiscal Q3 2011
Accession
0001354488-11-003435 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PHARMA-BIO SERV, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-07-319,475,502USD
At 2010-10-316,558,024USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-07-312,054,200USD
At 2010-10-311,488,553USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-07-317,421,302USD
At 2010-10-315,069,471USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-07-313,588,049USD
At 2011-04-302,552,989USD
At 2010-10-312,317,168USD
At 2010-07-311,929,126USD
At 2010-04-302,549,282USD
At 2009-10-312,051,874USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-05-01 to 2011-07-311,498,602USD92
2010-11-01 to 2011-07-312,334,554USD273
2010-05-01 to 2010-07-31121,409USD92
2009-11-01 to 2010-07-31188,748USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-05-01 to 2011-07-311,054,280USD92
2010-11-01 to 2011-07-311,347,425USD273
2010-05-01 to 2010-07-31-586,190USD92
2009-11-01 to 2010-07-31-25,444USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-05-01 to 2011-07-312,549USD92
2010-11-01 to 2011-07-3168,764USD273
2010-05-01 to 2010-07-317,562USD92
2009-11-01 to 2010-07-3127,617USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-05-01 to 2011-07-31-7,976USD92
2010-11-01 to 2011-07-31-17,791USD273
2010-05-01 to 2010-07-31-11,751USD92
2009-11-01 to 2010-07-31-38,378USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-05-01 to 2011-07-31-2,549USD92
2010-11-01 to 2011-07-31-68,764USD273
2010-05-01 to 2010-07-31-7,562USD92
2009-11-01 to 2010-07-31-27,617USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-07-316,775,281USD
At 2010-10-314,440,728USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-05-01 to 2011-07-3120,754,954shares92
2010-11-01 to 2011-07-3120,752,475shares273
2010-05-01 to 2010-07-3120,751,215shares92
2009-11-01 to 2010-07-3120,751,215shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2011-05-01 to 2011-07-3122,515,391shares92
2010-11-01 to 2011-07-3122,500,875shares273
2010-05-01 to 2010-07-3122,442,800shares92
2009-11-01 to 2010-07-3122,371,847shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2011-05-01 to 2011-07-310.072USD/shares92
2010-11-01 to 2011-07-310.112USD/shares273
2010-05-01 to 2010-07-310.006USD/shares92
2009-11-01 to 2010-07-310.009USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2011-05-01 to 2011-07-310.067USD/shares92
2010-11-01 to 2011-07-310.104USD/shares273
2010-05-01 to 2010-07-310.005USD/shares92
2009-11-01 to 2010-07-310.008USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-05-01 to 2011-07-31-328,268USD92
2010-11-01 to 2011-07-3195,840USD273
2010-05-01 to 2010-07-3184,822USD92
2009-11-01 to 2010-07-31153,299USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-07-311,240,514USD
At 2010-10-311,321,258USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-05-01 to 2011-07-312,166USD92
2010-11-01 to 2011-07-316,498USD273
2010-05-01 to 2010-07-314,830USD92
2009-11-01 to 2010-07-3133,548USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-05-01 to 2011-07-311,167,579USD92
2010-11-01 to 2011-07-312,421,861USD273
2010-05-01 to 2010-07-31204,759USD92
2009-11-01 to 2010-07-31332,388USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-07-318,214,781USD
At 2010-10-315,203,402USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-05-01 to 2011-07-312,575USD92
2010-11-01 to 2011-07-315,916USD273
2010-05-01 to 2010-07-311,497USD92
2009-11-01 to 2010-07-314,194USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-07-311,953,927USD
At 2010-10-311,434,714USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-07-314,117,647USD
At 2010-10-312,520,407USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-05-01 to 2011-07-311,999,504USD92
2010-11-01 to 2011-07-314,720,512USD273
2010-05-01 to 2010-07-31888,499USD92
2009-11-01 to 2010-07-312,396,417USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2011-05-01 to 2011-07-31831,925USD92
2010-11-01 to 2011-07-312,298,651USD273
2010-05-01 to 2010-07-31683,470USD92
2009-11-01 to 2010-07-312,064,029USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-07-3120,758,695shares
At 2010-10-3120,751,215shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-07-31-8,439USD
At 2010-10-31-19,218USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-07-3120,207USD
At 2010-10-3133,364USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2011-05-01 to 2011-07-311,170,334USD92
2010-11-01 to 2011-07-312,430,394USD273
2010-05-01 to 2010-07-31206,231USD92
2009-11-01 to 2010-07-31342,047USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-05-01 to 2011-07-3177,895USD92
2010-11-01 to 2011-07-31226,736USD273
2010-05-01 to 2010-07-3179,523USD92
2009-11-01 to 2010-07-31242,312USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-05-01 to 2011-07-312,755USD92
2010-11-01 to 2011-07-318,533USD273
2010-05-01 to 2010-07-311,472USD92
2009-11-01 to 2010-07-319,659USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-05-01 to 2011-07-31-145,283USD92
2010-11-01 to 2011-07-31-1,566,249USD273
2010-05-01 to 2010-07-31-849,220USD92
2009-11-01 to 2010-07-31-701,547USD273

Inspect the source

Entity
PHARMA-BIO SERV, INC. / CIK 0001304161
Captured
2026-09-19T11:17:27.241Z
SEC response SHA-256
bc9f33e072a9daa74aa0e8c41fbfef83d107920bc25647db80386f28787f2d49

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001304161.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))